Zeria Pharmaceutical Co., Ltd.
Zeria Pharmaceutical Co., Ltd., a prominent player in the pharmaceutical industry, is headquartered in Japan. Founded in 1923, the company has established a strong presence in various operational regions, focusing on the development and manufacturing of innovative healthcare solutions. Zeria is renowned for its expertise in prescription pharmaceuticals, particularly in the fields of gastrointestinal and infectious diseases. With a commitment to research and development, Zeria has achieved significant milestones, including the introduction of unique formulations that address unmet medical needs. The company’s core products are distinguished by their efficacy and safety profiles, positioning Zeria as a trusted name in the healthcare sector. Notably, Zeria Pharmaceutical has garnered recognition for its contributions to patient care, solidifying its market position as a leader in Japan and beyond.
DitchCarbon Score
How does Zeria Pharmaceutical Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Zeria Pharmaceutical Co., Ltd.'s score of 25 is lower than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Zeria Pharmaceutical Co., Ltd.'s reported carbon emissions
Zeria Pharmaceutical Co., Ltd., headquartered in Japan, currently does not report any specific carbon emissions data, as indicated by the absence of figures in the latest emissions data. Consequently, there are no recorded emissions in terms of Scope 1, 2, or 3. Additionally, Zeria Pharmaceutical has not established any formal reduction targets or climate pledges, which suggests a lack of publicly available commitments towards carbon neutrality or emissions reduction initiatives. The company does not inherit emissions data from a parent organisation, indicating that its climate strategy is independently developed. In the context of the pharmaceutical industry, where sustainability and climate commitments are increasingly critical, Zeria Pharmaceutical may need to consider establishing measurable targets and reporting frameworks to align with industry standards and stakeholder expectations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Zeria Pharmaceutical Co., Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
